Effects of different macromolecular models on reproducibility of FID-MRSI at 7T.


Journal

Magnetic resonance in medicine
ISSN: 1522-2594
Titre abrégé: Magn Reson Med
Pays: United States
ID NLM: 8505245

Informations de publication

Date de publication:
01 2020
Historique:
received: 13 03 2019
revised: 12 06 2019
accepted: 08 07 2019
pubmed: 9 8 2019
medline: 3 2 2021
entrez: 9 8 2019
Statut: ppublish

Résumé

A properly characterized macromolecular (MM) contribution is essential for accurate metabolite quantification in FID-MRSI. MM information can be included into the fitting model as a single component or parameterized and included over several individual MM resonances, which adds flexibility when pathologic changes are present but is prone to potential overfitting. This study investigates the effects of different MM models on MRSI reproducibility. Clinically feasible, high-resolution FID-MRSI data were collected in ~5 min at 7 Tesla from 10 healthy volunteers and quantified via LCModel (version 6.3) with 3 basis sets, each with a different approach for how the MM signal was handled: averaged measured whole spectrum (full MM), 9 parameterized components (param MM) with soft constraints to avoid overparameterization, or without any MM information included in the fitting prior knowledge. The test-retest reproducibility of MRSI scans was assessed voxel-wise using metabolite coefficients of variation and intraclass correlation coefficients and compared between the basis sets. Correlations of concentration estimates were investigated for the param MM fitting model. The full MM model provided the most reproducible quantification of total NAA, total Cho, myo-inositol, and glutamate + glutamine ratios to total Cr (coefficients of variations ≤ 8%, intraclass correlation coefficients ≥ 0.76). Using the param MM model resulted in slightly lower reproducibility (up to +3% higher coefficients of variations, up to -0.1 decreased intraclass correlation coefficients). The quantification of the parameterized macromolecules did not affect quantification of the overlapping metabolites. Clinically feasible FID-MRSI with an experimentally acquired MM spectrum included in prior knowledge provides highly reproducible quantification for the most common neurometabolites in healthy volunteers. Parameterization of the MM spectrum may be preferred as a compromise between quantification accuracy and reproducibility when the MM content is expected to be pathologically altered.

Identifiants

pubmed: 31393037
doi: 10.1002/mrm.27922
pmc: PMC6851974
doi:

Substances chimiques

Macromolecular Substances 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-21

Subventions

Organisme : Austrian Science Fund FWF
ID : KLI 718
Pays : Austria
Organisme : Austrian Science Fund FWF
ID : P 30701
Pays : Austria

Informations de copyright

© 2019 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals, Inc. on behalf of International Society for Magnetic Resonance in Medicine.

Références

Invest Radiol. 2017 Oct;52(10):631-639
pubmed: 28459799
NMR Biomed. 2016 Nov;29(11):1656-1665
pubmed: 27717093
Magn Reson Med. 2015 Sep;74(3):607-13
pubmed: 25252131
NMR Biomed. 2009 Aug;22(7):683-96
pubmed: 19259944
Magn Reson Med. 2018 Jun;79(6):2874-2885
pubmed: 29106742
Magn Reson Med. 2017 Jan;77(1):34-43
pubmed: 26800478
J Magn Reson Imaging. 2014 Jul;40(1):181-91
pubmed: 24395184
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
Magn Reson Med. 2016 Oct;76(4):1083-91
pubmed: 26502373
Magn Reson Med. 1993 Dec;30(6):672-9
pubmed: 8139448
Magn Reson Med. 2015 Jun;73(6):2062-8
pubmed: 24947343
Brain. 2001 May;124(Pt 5):953-61
pubmed: 11335697
Magn Reson Med. 2006 Dec;56(6):1200-10
pubmed: 17094090
Magn Reson Med. 2018 May;79(5):2460-2469
pubmed: 28868730
AJNR Am J Neuroradiol. 2006 Mar;27(3):684-8
pubmed: 16552016
NMR Biomed. 2006 Jun;19(4):484-91
pubmed: 16763968
Neuroimage. 2015 Nov 1;121:126-35
pubmed: 26210813
Neuroimage. 2018 Mar;168:211-221
pubmed: 28025130
NMR Biomed. 2018 Apr;31(4):e3898
pubmed: 29436038
J Magn Reson Imaging. 2017 Jan;45(1):187-198
pubmed: 27351712
Magn Reson Med. 2015 Jul;74(1):4-12
pubmed: 25081993
J Magn Reson Imaging. 2013 Aug;38(2):460-7
pubmed: 23292856
NMR Biomed. 2019 Feb;32(2):e4040
pubmed: 30489668
Magn Reson Med. 2017 Aug;78(2):429-440
pubmed: 27548836
Hum Brain Mapp. 2002 Nov;17(3):143-55
pubmed: 12391568
PLoS One. 2014 Dec 17;9(12):e115304
pubmed: 25517503
Neuroimage. 2018 Mar;168:199-210
pubmed: 27825954
MAGMA. 2016 Dec;29(6):863-874
pubmed: 27393351
NMR Biomed. 2010 Apr;23(3):251-6
pubmed: 19777506
J Magn Reson Imaging. 2004 Sep;20(3):366-71
pubmed: 15332241
NMR Biomed. 2013 Dec;26(12):1796-805
pubmed: 24038331
Magn Reson Med. 2018 Mar;79(3):1231-1240
pubmed: 28643447
Magn Reson Med. 2018 Aug;80(2):462-473
pubmed: 29334141
NMR Biomed. 2005 May;18(3):195-201
pubmed: 15884101
Magn Reson Med. 1994 Sep;32(3):294-302
pubmed: 7984061
J Magn Reson. 1997 Nov;129(1):35-43
pubmed: 9405214
Magn Reson Med. 2003 Jan;49(1):19-28
pubmed: 12509816
Neuroimage. 2005 Aug 1;27(1):222-30
pubmed: 15886023
Stroke. 2001 Dec 1;32(12):2797-802
pubmed: 11739976
J Alzheimers Dis. 2012;31 Suppl 3:S101-15
pubmed: 22543852
Radiology. 2014 Mar;270(3):658-79
pubmed: 24568703
Magn Reson Med. 2003 May;49(5):918-27
pubmed: 12704775
Magn Reson Med. 2016 Feb;75(2):503-14
pubmed: 25820200
NMR Biomed. 2012 Jun;25(6):873-82
pubmed: 22190245
NMR Biomed. 2013 May;26(5):593-9
pubmed: 23413241
Magn Reson Med. 2020 Jan;83(1):12-21
pubmed: 31393037
Magn Reson Med. 2017 Oct;78(4):1281-1295
pubmed: 27900794
J Neurochem. 2014 Jun;129(5):806-15
pubmed: 24611713
NMR Biomed. 2012 Apr;25(4):580-93
pubmed: 21858879

Auteurs

Eva Heckova (E)

High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Michal Považan (M)

Russell H. Morgan Department of Radiology and Radiological Science, The John Hopkins University School of Medicine, Baltimore, Maryland.

Bernhard Strasser (B)

Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Stanislav Motyka (S)

High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Gilbert Hangel (G)

High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Lukas Hingerl (L)

High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Philipp Moser (P)

High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Alexandra Lipka (A)

High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Stephan Gruber (S)

High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Siegfried Trattnig (S)

High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Christian Doppler Laboratory for Clinical Molecular MR Imaging, Vienna, Austria.

Wolfgang Bogner (W)

High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
Christian Doppler Laboratory for Clinical Molecular MR Imaging, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH